Summit Therapeutics
SMMT
SMMT
45 hedge funds and large institutions have $2.88M invested in Summit Therapeutics in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 5 increasing their positions, 16 reducing their positions, and 20 closing their positions.
Holders
45
Holders Change
-7
Holders Change %
-13.46%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
5
Reduced
16
Closed
20
Calls
$57K
Puts
–
Net Calls
+$57K
Net Calls Change
+$24K
Top Buyers
| 1 |
1
Millennium Management
New York
|
$457K |
| 2 |
AGM
2
Alpine Global Management
New York
|
$300K |
| 3 |
E
3
Ergoteles
New York
|
$101K |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$57K |
| 5 |
5
Renaissance Technologies
New York
|
$49K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
VOYA Investment Management
Atlanta,
Georgia
| – | -$26K | -10,629 | Closed |
|
|
AB
52
Amalgamated Bank
New York
| – | -$11K | -4,291 | Closed |
|
53
Legal & General Group
London,
United Kingdom
| – | -$7K | -2,770 | Closed |
|
|
AIP
54
Ameritas Investment Partners
Lincoln,
Nebraska
| – | -$4K | -1,762 | Closed |
|
55
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$4K | -1,620 | Closed |
|
56
Fidelity Investments
Boston,
Massachusetts
| – | -$2K | -729 | Closed |
|